The state of Alabama on Tuesday reached a $276 million settlement agreement with Endo Pharmaceutical, Johnson & Johnson, and McKesson for their role in exacerbating the opioid crisis.
The settlement will see pharmaceutical giant Johnson & Johnson pay $70.3 million in a lump-sum payment to Alabama state and its subdivisions this year, and Endo Pharmaceutical pay $25 million this year. Drug distributor McKesson will pay out $141 million to the state and its subdivisions over nine years.
